E Palazzo Selected Research

E Palazzo Research Topics

Disease

6	Pain (Aches) 04/2016 - 03/2000
5	Hyperalgesia 01/2010 - 01/2000
2	Rheumatoid Arthritis 04/2016 - 12/2001
2	Neoplasms (Cancer) 01/2016 - 09/2002
2	Neuralgia (Stump Neuralgia) 01/2010 - 02/2007
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2001 - 06/2000
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2001 - 06/2000
1	Colorectal Neoplasms (Colorectal Cancer) 07/2020
1	Microsatellite Instability 07/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Obesity 04/2016
1	Infections 06/2011
1	Gliosis 01/2010
1	Wounds and Injuries (Trauma) 01/2010
1	Psoriatic Arthritis 11/2007
1	Dermatomyositis (Dermatopolymyositis) 09/2005
1	Polymyositis 09/2005
1	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2005
1	Sclerosing Cholangitis 05/2003
1	Cardiotoxicity 09/2002
1	Endocarditis 07/2002
1	Sarcoidosis (Schaumann Disease) 01/2001
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2000
1	Syphilis 06/2000
1	Atrioventricular Block 03/2000
1	Nephritis 03/2000
1	Dystocia 03/2000
1	Fetal Distress 03/2000
1	Inflammation (Inflammations) 01/2000

Drug/Important Bio-Agent (IBA)

4	Formaldehyde (Formol)FDA Link 10/2007 - 01/2000
3	Analgesics (Analgesic Drugs)IBA 03/2007 - 01/2000
3	Biological ProductsIBA 05/2003 - 01/2001
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2003 - 07/2000
2	AntibodiesIBA 01/2001 - 06/2000
1	Poly AIBA 07/2020
1	Caspase 2IBA 07/2020
1	DNA (Deoxyribonucleic Acid)IBA 07/2020
1	Genetic Markers (Genetic Marker)IBA 07/2020
1	metabotropic glutamate receptor 6IBA 01/2020
1	CationsIBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	C-Reactive ProteinIBA 04/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016
1	tocilizumab (atlizumab)FDA Link 04/2016
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 06/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2011
1	pyrazoleIBA 01/2010
1	1- (2',4'- dichlorophenyl)- 6- methyl- N- cyclohexylamine- 1,4- dihydroindeno(1,2- c)pyrazole- 3 carboxamideIBA 01/2010
1	CyclohexylaminesIBA 01/2010
1	Peptide Hydrolases (Proteases)FDA Link 01/2010
1	CytokinesIBA 01/2010
1	CB2 Cannabinoid ReceptorIBA 01/2010
1	Anti-Citrullinated Protein AntibodiesIBA 11/2007
1	1,3-dipropyl-8-cyclopentylxanthineIBA 10/2007
1	Adenosine (Adenocard)FDA LinkGeneric 10/2007
1	arachidonoylserotoninIBA 03/2007
1	2-methylserineIBA 02/2007
1	methylserine phosphate (MSOP)IBA 02/2007
1	CarrageenanIBA 02/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2005
1	Docosahexaenoic AcidsIBA 09/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2002
1	FibrinIBA 07/2002
1	Glutamate Receptors (Glutamate Receptor)IBA 11/2001
1	N-Methylaspartate (NMDA)IBA 11/2001
1	oxidized low density lipoproteinIBA 01/2001
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2001
1	GalliumIBA 01/2001
1	Inosine Triphosphate (ITP)IBA 07/2000
1	Antiphospholipid AntibodiesIBA 06/2000
1	Immunoglobulin G (IgG)IBA 06/2000
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 06/2000
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2000
1	Prednisone (Sone)FDA LinkGeneric 03/2000
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2000

Therapy/Procedure

1	Analgesia 03/2007
1	Therapeutics 07/2000
1	Splenectomy 07/2000
1	Cesarean Section (Caesarean Section) 03/2000